E Fund Management Co. Ltd. Takes Position in Scholar Rock Holding Corporation $SRRK

E Fund Management Co. Ltd. acquired a new position in Scholar Rock Holding Corporation (NASDAQ:SRRK) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 9,256 shares of the company’s stock, valued at approximately $509,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of SRRK. IFP Advisors Inc grew its position in shares of Scholar Rock by 294.1% in the fourth quarter. IFP Advisors Inc now owns 603 shares of the company’s stock valued at $27,000 after purchasing an additional 450 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in Scholar Rock during the 4th quarter valued at about $30,000. Summit Securities Group LLC bought a new stake in shares of Scholar Rock during the fourth quarter valued at about $31,000. EverSource Wealth Advisors LLC increased its position in shares of Scholar Rock by 151.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 872 shares of the company’s stock valued at $38,000 after buying an additional 525 shares during the period. Finally, Hilton Head Capital Partners LLC purchased a new stake in shares of Scholar Rock in the fourth quarter worth about $44,000. Institutional investors own 91.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on SRRK. Weiss Ratings reissued a “sell (d-)” rating on shares of Scholar Rock in a report on Friday, July 17th. Citigroup lifted their price objective on Scholar Rock from $58.00 to $60.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Cantor Fitzgerald restated an “overweight” rating on shares of Scholar Rock in a research note on Thursday, June 18th. Barclays lifted their price target on Scholar Rock from $53.00 to $55.00 and gave the company an “overweight” rating in a research report on Friday, May 8th. Finally, BMO Capital Markets restated an “outperform” rating and issued a $76.00 price objective on shares of Scholar Rock in a research report on Friday, August 7th. Four analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Scholar Rock currently has an average rating of “Buy” and an average target price of $58.31.

Insider Activity at Scholar Rock

In other Scholar Rock news, Director Joshua Reed sold 3,053 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $53.74, for a total transaction of $164,068.22. Following the completion of the transaction, the director owned 19,518 shares of the company’s stock, valued at $1,048,897.32. This represents a 13.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Jeffrey S. Flier sold 3,053 shares of Scholar Rock stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $53.88, for a total value of $164,495.64. Following the completion of the sale, the director owned 27,856 shares in the company, valued at approximately $1,500,881.28. This represents a 9.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 17,149 shares of company stock valued at $923,108 in the last quarter. 10.30% of the stock is currently owned by company insiders.

Scholar Rock Stock Performance

Shares of SRRK stock opened at $55.25 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 7.02 and a current ratio of 7.02. Scholar Rock Holding Corporation has a fifty-two week low of $27.07 and a fifty-two week high of $58.49. The stock has a 50 day moving average price of $51.61 and a two-hundred day moving average price of $48.42. The company has a market capitalization of $6.73 billion, a P/E ratio of -16.01 and a beta of 0.69.

Scholar Rock (NASDAQ:SRRK) last issued its earnings results on Thursday, August 6th. The company reported ($0.84) EPS for the quarter, hitting the consensus estimate of ($0.84). During the same quarter in the previous year, the company earned ($0.98) earnings per share. Analysts expect that Scholar Rock Holding Corporation will post -3.23 earnings per share for the current year.

About Scholar Rock

Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company’s research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock’s approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.

The company’s lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).